Scinovex
article Open AccessTop 10% cited

<i>Citrus limon</i>-derived nanovesicles inhibit cancer cell proliferation and suppress CML xenograft growth by inducing TRAIL-mediated cell death

Oncotarget · 2015 · Vol. 6(23) · pp. 19514–19527
Stefania RaimondoFlores NaselliSimona FontanaFrancesca Villafiorita‐MonteleoneAlessia Lo DicoLaura SaievaGiovanni ZitoA. FlugýMauro MannoMaria Antonietta Di BellaGiacomo De LeoRiccardo Alessandro

Abstract

Nanosized vesicles are considered key players in cell to cell communication, thus influencing physiological and pathological processes, including cancer. Nanovesicles have also been found in edible-plants and have shown therapeutic activity in inflammatory bowel diseases; however information on their role in affecting cancer progression is missing.Our study identify for the first time a fraction of vesicles from lemon juice (Citrus limon L.), obtained as a result of different ultracentrifugation, with density ranging from 1,15 to 1,19 g/ml and specific proteomic profile. By using an in vitro approach, we show that isolated nanovesicles inhibit cancer cell proliferation in different tumor cell lines, by activating a TRAIL-mediated apoptotic cell death. Furthermore, we demonstrate that lemon nanovesicles suppress CML tumor growth in vivo by specifically reaching tumor site and by activating TRAIL-mediated apoptotic cell processes. Overall, this study suggests the possible use of plant-edible nanovesicles as a feasible approach in cancer treatment.

Extracellular vesicles in diseaseRNA Interference and Gene DeliveryGalectins and Cancer BiologyApoptosisCell growthCancerProgrammed cell deathCancer researchCancer cellCellIn vitroBiologyMedicine

MeSH terms

Fruit and Vegetable JuicesAnimalsAntineoplastic Agents, PhytogenicCell SurvivalCitrusHumansMalePhytotherapyPlant ExtractsPlant ProteinsPlants, MedicinalTime FactorsSignal TransductionLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMice, SCID

Funding

  • Università degli Studi di Palermo
  • Associazione Italiana per la Ricerca sul Cancro
  • Fondazione Ri.Med
  • Programma Operativo Nazionale Ricerca e Competitività
Citations
472
FWCI
4.67
field-weighted impact
References
32
Percentile
95%
vs. same field & year
Citations per year
Cited by
Advances in therapeutic applications of extracellular vesicles
Science Translational Medicine · 2019 · 983 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.